🧪Trial version — For internal lab review only. Not for clinical or production use.
VaxIQ/Haemophilus influenzae b (Hib)
← Back to VaxIQ

Haemophilus influenzae b (Hib)

Haemophilus influenzae type b Conjugate Vaccine

Tier 2 · ExtendedVaccineCuration in progress

Platform: Conjugate

Vaccine that protects against Haemophilus influenzae type b, a cause of bacterial meningitis and pneumonia in young children.

anti-PRPconjugatepediatricinvasive disease

Immunology Sections

Curated section analysis in progress

Structured immunology sections — mechanism, immune response, molecular signatures, correlates of protection, and more — are being prepared by the Precision Vaccines Program team. In the meantime, verified references and live literature from PubMed, Semantic Scholar, and Wikipedia are available below.

MechanismImmune ResponseMolecular & Immune SignaturesCorrelates of ProtectionOpen QuestionsImmunogenicitySafetyInfection Immunology

Wikipedia Overview

Full article ↗
Hib vaccine

The Haemophilus influenzae type B vaccine, also known as Hib vaccine, is a vaccine used to prevent Haemophilus influenzae type b (Hib) infection. In countries that include it as a routine vaccine, rates of severe Hib infections have decreased more than 90%. It has therefore resulted in a decrease in the rate of meningitis, pneumonia, and epiglottitis.

PubMed Literature

Search PubMed ↗

No PubMed results retrieved.

Semantic Scholar

Search S2 ↗

No Semantic Scholar results retrieved.